Feed BVNRY
BV
Bavarian Nordic A/S BVNRY · OTC
$12.27 +2.51% (+$0.30)
Depth
- Market cap
- 20.0B kr
- Enterprise value
- 19.3B kr
- P/E
- 12.8x
- Forward P/E
- 17.3x
- PEG
- 0.4x
- P/S
- 3.3x
- P/FCF
- 16.3x
- EV/EBITDA
- 7.3x
- ROIC
- 5.7%
- Gross margin
- 51.7%
- Net margin
- 25.6%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -0.2x
- Beta
- 0.94
- Free float
- 33.0%
Sector
Healthcare
Industry
Biotechnology
CEO
Tarja Stenvall
Employees
1,795
Headquarters
Hellerup
Valuation
Is today's price reasonable?
- What speaks for it: You pay 12.8 DKK for 1 DKK of yearly profit, little for its sector.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Revenue grew by 23% a year over the last 3 years.
- What to watch: It missed profit estimates 4 times in the last 8 quarters.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 DKK of revenue, 26 DKK is left as net profit.
- What to watch: It earns only 5.7 DKK a year on every 100 DKK of invested capital.
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: 776.7M kr against 131.3M kr.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number